Does RIMABOTULINUMTOXINB Cause Atypical mycobacterial infection? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Atypical mycobacterial infection have been filed in association with RIMABOTULINUMTOXINB (Myobloc). This represents 6.3% of all adverse event reports for RIMABOTULINUMTOXINB.
11
Reports of Atypical mycobacterial infection with RIMABOTULINUMTOXINB
6.3%
of all RIMABOTULINUMTOXINB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Atypical mycobacterial infection From RIMABOTULINUMTOXINB?
Of the 11 reports.
Is Atypical mycobacterial infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIMABOTULINUMTOXINB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does RIMABOTULINUMTOXINB Cause?
Death (34)
Product use in unapproved indication (32)
Dysphagia (17)
Dry mouth (15)
Off label use (15)
Drug ineffective (14)
Headache (10)
Nausea (9)
Asthenia (7)
Dizziness (7)
What Other Drugs Cause Atypical mycobacterial infection?
METHOTREXATE (137)
TACROLIMUS (106)
MYCOPHENOLATE MOFETIL (98)
PREDNISOLONE (96)
PREDNISONE (79)
INFLIXIMAB (60)
CYCLOSPORINE (53)
METHYLPREDNISOLONE (47)
TOCILIZUMAB (44)
AZATHIOPRINE (42)
Which RIMABOTULINUMTOXINB Alternatives Have Lower Atypical mycobacterial infection Risk?
RIMABOTULINUMTOXINB vs RIMEGEPANT
RIMABOTULINUMTOXINB vs RIOCIGUAT
RIMABOTULINUMTOXINB vs RIPRETINIB
RIMABOTULINUMTOXINB vs RISANKIZUMAB
RIMABOTULINUMTOXINB vs RISANKIZUMAB-RZAA